Invitae - Invitae Unveils New Research for Breast Cancer …
https://ir.invitae.com/news-and-events/press-releases/press-release-details/2024/Invitae-Unveils-New-Research-for-Breast-Cancer-Patients-with-Variants-of-Uncertain-Significance/default.aspx
WEBApr 11, 2024 · Invitae (OTC: NVTA), a leading medical genetics company, today announced new studies to be presented at the American Society of Breast Surgeons Annual Meeting (ASBrS) held in Orlando from April 10-14, 2024. The featured research will highlight how machine learning can reduce variants of uncertain significance (VUS) in …
DA: 44 PA: 26 MOZ Rank: 72